期刊文献+

拉坦前列素滴眼液对人眼球筋膜囊成纤维细胞增殖的影响 被引量:1

Effects of latanoprost eye drops on the proliferation of human Tenon′s fibroblasts in tissue culture
原文传递
导出
摘要 目的研究拉坦前列素滴眼液对体外培养的人眼球筋膜囊成纤维细胞的增殖有无促进作用。方法体外培养人眼球筋膜囊成纤维细胞。按1∶10比例逐级稀释拉坦前列素滴眼液(0.005%),使药物浓度依次为5.00、0.50、0.05μg/ml直至5×10-8μg/ml。采用噻唑蓝比色法检测在不同浓度药物作用下的细胞增殖情况,并在光学显微镜下观察细胞的形态变化。结果较高浓度组(5.00μg/ml)拉坦前列素滴眼液对人眼球筋膜囊成纤维细胞存在明显的杀伤作用,细胞几乎全部死亡,吸光度(A)值与对照组相比明显下降(P<0.01);低浓度组(<0.05μg/ml)A值较对照组无明显变化(P>0.05)。比较拉坦前列素滴眼液在不同作用时间下的剂量效应曲线,24、48及72h差异均无统计学意义(P>0.05)。结论拉坦前列素滴眼液不能促进体外培养的人眼球筋膜囊成纤维细胞的增殖,在较高浓度时具有细胞毒性,在较低浓度时则对细胞增殖无明显影响。 Objective To observe whether there is a direct effect of latanoprost eye drops on the proliferation of cultured human Tenon′s capsule fibroblasts (HTCFs) in vitro.Methods Human Tenon′s capsule fibroblasts were cultured in vitro. Latanoprost eye drops was serially diluted in order to make nine concentrations ranging from 5.00 μg/ml, 0.50 μg/ml, 0.05 μg/ml to 5×10 -8 μg/ml. Fibroblasts growth was evaluated with MTT assay. Morphological changes were observed under phase contrast microscope. Results Majority of cultured human Tenon′s capsule fibroblasts was dead at the concentration of Latanoprost (5 μg/ml) , the A values were significantly decreased (P<0.01). There were no significant changes of the A values (P>0.05) in lower concentration (under 0.05 μg/ml) compared with control. there was no statistical difference in proliferation of HTCFs after latanoprost treatment for 24 hours, 48 hours, 72 hours. Conclusions Latanoprost has the toxic effect on the fibroblast at higher concentrations, but there is no influence on the proliferation of HTCFs at the lower concentrations.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2005年第7期620-624,共5页 Chinese Journal of Ophthalmology
  • 相关文献

参考文献9

  • 1Broadway DC,Grierson I,O′Brien C,et al. Adverse effects of topical antiglaucoma medication:I. the conjunctival cell profile. Arch Ophthalmol,1994,112:1437-1445.
  • 2Broadway DC,Grierson I,O′Brien C,et al. Adverse effects of topical antiglaucoma medication:II. the outcome of filtration surgery. Arch Ophthalmol,1994,112:1446-1454.
  • 3Cunliffe IA,McIntyre CA,Rees RC,et al. Pilot study on the effect of topical adrenergic medications on human Tenon′s capsule fibroblasts in tissue culture. Br J Ophthalmol,1995,79:70-75.
  • 4Williams DE,Nguyen KD,Shapourifar-Tehrani S,et al. Effects of timolol, betaxolol, and levobunolol on human Tenon′s fibroblasts in tissue culture. Invest Ophthalmol Vis Sci,1992,33:2233-2241.
  • 5Baudouin C,Pisella PJ,Fillacier K,et al. Ocular surface inflammmatory changes induced by topical antiglaucoma drugs:human and animal studies. Ophthalmology,1999,106:556-563.
  • 6Lark KK,Pasha AS,Yan X,et al. The effect of latanoprost and brimonidine on rabbit subconjunctival fibroblasts. J Glaucoma,1999,8:72-76.
  • 7Pisella PJ,Debbasch C,Hamard P,et al. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol:an ex vivo and in vitro study. Invest Ophthalmol Vis Sci,2004,45:1360-1368.
  • 8Sjoquist B,Basu S,Byding P,et al. The pharmacokinetics of a new antiglaucoma drug,latanoprost,in the rabbit. Drug Metab Disp,1998,26: 745-754.
  • 9Sjoquist B,Stjernschantz J. Ocular and systemic pharmacokinetics of latanoprostin humans. Surv Ophthalmol,2002,47(suppl 1):S6-S12

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部